Mar 3, 2026 04:16PM

Mar 3, 2026 04:15PM

Aug 11, 2025 07:00AM

Aug 8, 2024 07:00AM

May 30, 2024 07:00AM

Apr 2, 2024 07:02AM

Apr 2, 2024 07:00AM Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma

100,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All